SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA ARTICLE M impact

Pfizer Strikes $2.6 Billion Deal for Experimental Autoimmune Therapies

Pfizer licensed exclusive rights outside Greater China to develop, manufacture and commercialize three experimental autoimmune treatments from Starna Therapeutics.

PFE

By Connor HartPfizer entered into a licensing agreement with Starna Therapeutics, obtaining exclusive rights outside Greater China to develop, manufacture and commercialize three early-stage, experimental treatments for autoimmune diseases.Under the agreement, Starna will receive an upfront payment…

Related stories